What is the appropriate management for a hypertensive patient with peeling skin on the palms and feet?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Evaluation and Management of Palmoplantar Skin Peeling in a Hypertensive Patient

Immediate Priority: Rule Out Drug-Induced Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis

This patient requires urgent evaluation to exclude Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (SJS/TEN), a potentially life-threatening drug reaction that characteristically involves the palms and soles prominently. 1, 2

Critical Assessment Steps

Examine for features that distinguish SJS/TEN from benign causes:

  • Assess for cutaneous pain - This is a prominent early feature in SJS/TEN and should immediately alert you to incipient epidermal necrolysis 1, 2
  • Check for mucosal involvement - Erosive and hemorrhagic mucositis of the eyes, mouth, nose, or genitalia is usually an early feature of SJS/TEN 1, 2
  • Evaluate the rash pattern - SJS/TEN typically begins on the upper torso, proximal limbs, and face before spreading, with prominent palmoplantar involvement 1, 2
  • Test for Nikolsky sign - Gentle lateral pressure causing epidermal detachment indicates epidermal necrolysis, though this is not specific for SJS/TEN 1, 2
  • Look for atypical target lesions - Dark red center surrounded by pink ring, or purpuric macules that are tender to touch 1, 2

Medication Review for SJS/TEN Risk

Review all antihypertensive medications started within the past 8 weeks, as drug-induced cytotoxic T lymphocyte activation is the primary mechanism of SJS/TEN 1:

  • Common culprits include sulfonamides, anticonvulsants, allopurinol, and NSAIDs 1
  • If SJS/TEN is suspected, immediately discontinue the offending medication and refer for emergency hospitalization 1

Alternative Diagnosis: Acitretin-Related or Retinoid Dermatitis

If the patient is not on retinoids but the presentation suggests retinoid-like effects, consider:

  • Thinning, redness, and scaling of skin particularly on palms and soles is a characteristic side effect of acitretin and other retinoids 1
  • This causes increased sensitivity and fragility making walking and grasping objects difficult 1
  • However, this patient is not described as being on retinoids, making this less likely 1

Most Likely Diagnosis: Acral Peeling Skin Syndrome or Benign Palmoplantar Desquamation

If SJS/TEN features are absent and the patient has painless peeling limited to acral surfaces:

  • Acral peeling skin syndrome presents as spontaneous asymptomatic peeling limited to palms and soles 3
  • This is typically a chronic condition with abnormal keratohyalin granules causing separation in the stratum corneum 3
  • Peeling skin syndrome can involve palms and soles in some variants 4

Management Algorithm

Step 1: Emergency Triage (Complete Within 1 Hour)

  • If ANY of the following are present, arrange immediate hospital transfer: 1, 2
    • Cutaneous pain or tenderness
    • Positive Nikolsky sign
    • Mucosal involvement (oral, ocular, genital erosions)
    • Atypical target lesions or purpuric macules
    • Systemic symptoms (fever, malaise)

Step 2: Hypertension Management Considerations

Optimize blood pressure control while investigating the skin condition:

  • Current blood pressure status should be assessed with repeated measurements in both arms 5
  • For this 48-year-old hypertensive male, target BP should be <130/80 mmHg if he has diabetes, chronic kidney disease, or 10-year cardiovascular risk ≥10% 1, 5
  • Avoid medication changes that could confound the dermatologic diagnosis until the cause of peeling is determined 1

Important caveat: Beta-blockers and calcium channel blockers are NOT contraindicated in psoriasis patients despite older concerns, and there is no evidence supporting avoidance of particular antihypertensives based on dermatologic conditions 1

Step 3: Dermatologic Workup (If SJS/TEN Excluded)

For painless palmoplantar peeling without systemic features:

  • Obtain skin biopsy from the edge of peeling area before and potentially after water immersion 3
  • Light and electron microscopy to evaluate for abnormal keratohyalin granules and keratin filament aggregation 3
  • Consider fungal culture and KOH preparation to exclude tinea manuum/pedis
  • Review for contact dermatitis exposures (occupational, household chemicals)

Step 4: Symptomatic Management

While awaiting definitive diagnosis:

  • Apply emollients and barrier creams to affected areas
  • Avoid irritants and excessive water exposure
  • Consider low-potency topical corticosteroids if inflammatory component present
  • Do NOT use high-potency topical steroids on palms/soles without dermatology consultation, as this can mask serious conditions

Critical Pitfalls to Avoid

  • Never dismiss palmoplantar involvement as "just dry skin" in a patient on multiple medications - SJS/TEN prominently involves palms and soles 1, 2
  • Do not attribute skin changes to hypertension itself - hypertension does not cause palmoplantar peeling 1
  • Avoid rapid antihypertensive medication changes without first establishing the dermatologic diagnosis, as this may confound causality assessment 5
  • Do not delay referral if any features suggest SJS/TEN, as mortality increases with delayed recognition and continued drug exposure 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Clinical Characteristics

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Acral peeling skin syndrome.

Journal of the American Academy of Dermatology, 2000

Research

Peeling skin syndrome.

European journal of dermatology : EJD, 2006

Guideline

Management of Severe Hypertension

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.